AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.AbbVie Inc. (ABBV) shares rose 2.45% to $263.20, outperforming the broader market and hitting a new 52-week high. While competitors like Pfizer and Amgen also gained, AbbVie's trading volume remained below its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) advanced 2.45% to $263.20 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,428.78 and the Dow Jones Industrial Average rising 1.03% to 52,747.32.
AbbVie Inc. hit a new 52-week high, surpassing its previous peak of $262.10, which the company achieved on July 27th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.29% to $266.73, Pfizer Inc. (PFE) rose 2.35% to $25.25, and Amgen Inc. (AMGN) rose 4.48% to $393.10.
Trading volume (6.8 M) remained 183,983 below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-28-26 1632ET